{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-015928","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2022-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.094662+00:00","generated_at":"2026-06-24T22:58:45.528656+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Reviva Pharmaceuticals CMO Marc Cantillon resigns effective July 5, 2022","bullets":["Marc Cantillon resigns as Chief Medical Officer effective July 5, 2022, to pursue other opportunities.","Resignation not due to disagreements with company operations, policies, or practices.","Company has commenced search for new clinical management; will use independent consultants in the interim."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-015928","json":"https://secwatch.observer/filing/0001437749-22-015928.json","markdown":"https://secwatch.observer/filing/0001437749-22-015928.md","text":"https://secwatch.observer/filing/0001437749-22-015928.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/0001437749-22-015928-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/rvph20220624_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:58:45.528656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee6d45fc32","claim":"Marc Cantillon resigned as Chief Medical Officer at REVIVA PHARMACEUTICALS HOLDINGS, INC..","evidence_excerpt":"On June 23, 2022, Marc Cantillon, the Chief Medical Officer of Reviva Pharmaceuticals Holdings, Inc. (the “Company”), notified the Company that he will resign as Chief Medical Officer of the Company effective as of July 5, 2022 to pursue additional opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/0001437749-22-015928-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}